drugset / Trial / NCT06209138
5-fluorouracil for Treatment of Stable Vitiligo
RandomizedParallel-groupOpen-labelTreatment
Summary
Vitiligo, a significant dermatologic challenge affecting 0.5 to 2% of the global population. Despite various existing medical approaches, current vitiligo treatments are still far from optimal.
Timeline
- Start
- 2024-01-23
- Primary completion
- 2024-04-15
- Completion
- 2024-04-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | fluorouracil | Small molecule | — | — |